)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Intra-Cellular Therapies
Intra-Cellular Therapies (ITCI) investor relations material
Intra-Cellular Therapies has been delisted
Intra-Cellular Therapies Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary21 Feb, 2025
Executive summary
CAPLYTA net product sales reached $199.2M in Q4 2024, up 51% year-over-year; full-year 2024 sales were $680.5M, a 47% increase.
FDA accepted the sNDA for lumateperone as adjunctive treatment for major depressive disorder (MDD).
Field sales force expansion began in Q1 2025 in anticipation of potential MDD approval.
Financial highlights
SG&A expenses rose to $504.5M in 2024 from $409.9M in 2023, mainly due to commercialization and marketing.
R&D expenses increased to $236.1M in 2024 from $180.1M in 2023, reflecting higher project costs.
Cash, cash equivalents, investment securities, and restricted cash totaled $1.0B at year-end 2024, up from $499.7M at year-end 2023.
Net loss for Q4 2024 was $16.9M ($0.16/share); full-year net loss was $74.7M ($0.72/share), improved from $139.7M loss in 2023.
Outlook and guidance
Anticipates potential FDA approval and commercial launch of CAPLYTA for adjunctive MDD treatment.
Ongoing expansion of sales force to support expected growth.
Explain the increase in SG&A expenses.
Assess the likelihood of sNDA approval for MDD.
Discuss the strategy behind sales force expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Intra-Cellular Therapies
- Lumateperone showed robust efficacy and safety as adjunctive therapy in MDD Phase 3 trials.ITCI
Study Result3 Feb 2026 - Caplyta sales surged 46% in Q2 2024, driving improved results and a higher 2024 outlook.ITCIQ2 20242 Feb 2026
- MDD sNDA filing expected this year, with pipeline and sales force expansion progressing.ITCICanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- Strong growth in mood disorders, pipeline expansion, and robust prescriber base drive outlook.ITCIGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- CAPLYTA's growth accelerates with new indications, pivotal trials, and strong financials.ITCIJefferies 2024 Global Healthcare Conference1 Feb 2026
- CAPLYTA's strong growth and clinical success drive expansion into MDD and broader CNS markets.ITCIMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
- CAPLYTA’s growth accelerates with new indications and a rich pipeline, backed by strong finances.ITCIBaird's 2024 Global Healthcare Conference21 Jan 2026
- Caplyta's robust growth and broadening indications drive major expansion into mood disorder markets.ITCI2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Q3 2024 net sales up 39% year-over-year; guidance raised on strong growth and pipeline.ITCIQ3 202417 Jan 2026
- MDD approval is set to accelerate growth, supporting a $5B market opportunity in five years.ITCI7th Annual Evercore ISI HealthCONx Conference12 Jan 2026
Intra-Cellular Therapies
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage